Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company targeting to revolutionize life-science product development.
INVESTOR RELATIONS CONTACT
Rachel Pomerantz Gerber
Head of Investor Relations at Evogene
+972-8-9311901